{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:11:31Z","timestamp":1791004291182,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.jmgm.2015.11.013","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T11:48:36Z","timestamp":1448452116000},"page":"49-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["An in-silico approach aimed to clarify the role of Y181C and K103N HIV-1 reverse transcriptase mutations versus Indole Aryl Sulphones"],"prefix":"10.1016","volume":"63","author":[{"given":"Alberto","family":"Massarotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7940-8206","authenticated-orcid":false,"given":"Antonio","family":"Coluccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2015.11.013_bib0005","unstructured":"UNAIDS. MDG 6: 15 years, 15 lessons of hope from the aids response, 2014."},{"issue":"Pt. 2","key":"10.1016\/j.jmgm.2015.11.013_bib0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.coviro.2013.03.014","article-title":"HIV-1 reverse transcriptase and antiviral drug resistance","volume":"3","author":"Das","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0015","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3390\/v1031137","article-title":"Mutation rates and intrinsic fidelity of retroviral reverse transcriptases","volume":"1","author":"Menendez-Arias","year":"2009","journal-title":"Viruses"},{"key":"10.1016\/j.jmgm.2015.11.013_bib0020","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0802203105","article-title":"Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection","volume":"105","author":"Keele","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.tips.2004.11.003","article-title":"HIV reverse transcriptase structures: designing new inhibitors and understanding mechanisms of drug resistance","volume":"26","author":"Ren","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0030","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcv.2004.02.009","article-title":"Antiviral drugs in current clinical use","volume":"30","author":"De Clercq","year":"2004","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0035","doi-asserted-by":"crossref","first-page":"8046","DOI":"10.1073\/pnas.92.17.8046","article-title":"Human immunodeficiency virus reverse transcriptase substrate-induced conformational changes and the mechanism of inhibition by nonnucleoside inhibitors","volume":"92","author":"Rittinger","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nsb0495-293","article-title":"High resolution structures of HIV-1 RT from four RT-inhibitor complexes","volume":"2","author":"Ren","year":"1995","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0045","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/00042560-199604010-00002","article-title":"Use of chimeric human immunodeficiency virus types 1 and 2 reverse transcriptases for structure-function analysis and for mapping susceptibility to nonnucleoside inhibitors","volume":"11","author":"Yang","year":"1996","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0050","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1073\/pnas.0711209105","article-title":"High-resolution structures of HIV-1 reverse transcriptase\/TMC278 complexes: strategic flexibility explains potency against resistance mutations","volume":"105","author":"Das","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0055","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1021\/jm1002233","article-title":"Crystal structures of HIV-1 reverse transcriptase with etravirine (TMC125) and rilpivirine (TMC278): implications for drug design","volume":"53","author":"Lansdon","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0060","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1021\/jm0211063","article-title":"Novel indolyl aryl sulfones active against HIV-1 carrying NNRTI resistance mutations: synthesis and SAR studies","volume":"46","author":"Silvestri","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0065","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1021\/jm031147e","article-title":"Simple, short peptide derivatives of a sulfonylindolecarboxamide (L-737,126) active in vitro against HIV-1 wild type and variants carrying non-nucleoside reverse transcriptase inhibitor resistance mutations","volume":"47","author":"Silvestri","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0070","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1021\/jm801470b","article-title":"Indolylarylsulfones bearing natural and unnatural amino acids. Discovery of potent inhibitors of HIV-1 non-nucleoside wild type and resistant mutant strains reverse transcriptase and coxsackie B4 virus","volume":"52","author":"Piscitelli","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0075","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1021\/jm0512490","article-title":"Design, molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamide","volume":"49","author":"Ragno","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0080","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.1021\/jm300477h","article-title":"New nitrogen containing substituents at the indole-2-carboxamide yield high potent and broad spectrum indolylarylsulfone HIV-1 non-nucleoside reverse transcriptase inhibitors","volume":"55","author":"La Regina","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0085","doi-asserted-by":"crossref","first-page":"9945","DOI":"10.1021\/jm5011622","article-title":"Indolylarylsulfones carrying a heterocyclic tail as very potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors","volume":"57","author":"Famiglini","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0090","unstructured":"R.W. Shafer, Genotypic Testing for HIV-1 Drug Resistance 2004."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0095","doi-asserted-by":"crossref","first-page":"11241","DOI":"10.1073\/pnas.88.24.11241","article-title":"Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture","volume":"88","author":"Richman","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0100","doi-asserted-by":"crossref","first-page":"12773","DOI":"10.1128\/JVI.79.20.12773-12782.2005","article-title":"TMC125 displays a high genetic barrier to the development of resistance: evidence from in vitro selection experiments","volume":"79","author":"Vingerhoets","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0105","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00126334-200402010-00004","article-title":"Characterization of nevirapine resistance mutations in women with subtype A vs:D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012)","volume":"35","author":"Eshleman","year":"2004","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0110","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1128\/AAC.01695-10","article-title":"Connection domain mutations in HIV-1 reverse transcriptase do not impact etravirine susceptibility and virologic responses to etravirine-containing regimens","volume":"55","author":"Gupta","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0115","first-page":"65","article-title":"Mutations in retroviral genes associated with drug resistance: 2000\u20132001 update","volume":"8","author":"Schinazi","year":"2000","journal-title":"Int. AntiVir. News."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0120","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0969-2126(00)00513-X","article-title":"Structural basis for the resilience of efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptase","volume":"8","author":"Ren","year":"2000","journal-title":"Structure"},{"key":"10.1016\/j.jmgm.2015.11.013_bib0125","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1006\/jmbi.2001.4648","article-title":"The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance","volume":"309","author":"Hsiou","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0130","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.bmcl.2007.11.085","article-title":"Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)","volume":"18","author":"Zhao","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0135","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0140","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1006\/jmbi.1996.0698","article-title":"Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant","volume":"264","author":"Das","year":"1996","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.antiviral.2008.09.008","article-title":"Non-nucleoside HIV-1 reverse transcriptase inhibitors di-halo-indolyl aryl sulfones achieve tight binding to drug-resistant mutants by targeting the enzyme-substrate complex","volume":"81","author":"Samuele","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0150","first-page":"762","article-title":"Essential dynamics: foundation and applications","volume":"2","author":"Daidone","year":"2012","journal-title":"Wiley Interdiscip. Rev.: Comput. Mol. Sci."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0155","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nprot.2012.004","article-title":"Topological analysis and interactive visualization of biological networks and protein structures","volume":"7","author":"Doncheva","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0160","unstructured":"PyMOL version1.2r1. DeLanoScientificLLC: SanCarlos, CA."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0165","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0170","unstructured":"Molecular Operating Environment (MOE), 2009.10. Chemical Computing Group Inc., 1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11721-007-0006-9","article-title":"An ant colony optimization approach to flexible protein-ligand docking","volume":"1","author":"Korb","year":"2007","journal-title":"Swarm Intell."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0180","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","article-title":"Automatic atom type and bond type perception in molecular mechanical calculations","volume":"25","author":"Wang","year":"2006","journal-title":"J. Mol. Graphics Modell."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0185","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0190","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theor. Comp."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0195","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0200","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/prot.10613","article-title":"A hierarchical approach to all-atom protein loop prediction","volume":"55","author":"Jacobson","year":"2004","journal-title":"Proteins"},{"key":"10.1016\/j.jmgm.2015.11.013_bib0205","unstructured":"D.E.B. Gomes, A.W. da Silva, R.D. Lins, P.G. Pascutti, T.A. Soares, Porcupine (2012), http:\/\/lmdm.biof.ufrj.br\/software\/porcupine\/index.html."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0210","doi-asserted-by":"crossref","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0215","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0220","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tibs.2011.01.002","article-title":"Analyzing and visualizing residue networks of protein structures","volume":"36","author":"Doncheva","year":"2011","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jmgm.2015.11.013_bib0225","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326315300875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326315300875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:51:05Z","timestamp":1761079865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326315300875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":45,"alternative-id":["S1093326315300875"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2015.11.013","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An in-silico approach aimed to clarify the role of Y181C and K103N HIV-1 reverse transcriptase mutations versus Indole Aryl Sulphones","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2015.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}